Shirakawa Yuji, Uemura Kazuhisa, Kumegawa Shinji, Ueno Kazuki, Iwanishi Hiroki, Saika Shizuya, Asamura Shinichi
Department of Plastic and Reconstructive Surgery, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Department of Ophthalmology, Wakayama Medical University, Wakayama City, Wakayama, Japan.
Arch Plast Surg. 2023 Aug 28;50(5):446-451. doi: 10.1055/s-0043-1770082. eCollection 2023 Sep.
Elderly patients often have complications of blepharoptosis surgery that can result in the appearance or exacerbation of superficial punctate keratopathy (SPK). However, postoperative changes to SPK status have not been previously reported. We used subjective assessment of symptoms and measurement of SPK scale classification to investigate the safety and efficacy of blepharoptosis surgery in elderly patients. Included in this prospective study were 22 patients (44 eyes) with bilateral blepharoptosis that underwent surgery. Patients comprised 8 males and 14 females with a mean (±standard deviation) age of 75.7 ± 8.2 years (range: 61-89). Blepharoptosis surgery consisted of transcutaneous levator advancement and blepharoplasty including resection of soft tissue (skin, subcutaneous tissue, and the orbicularis oculi muscle). Margin reflex distance-1 (MRD-1) measurement, a questionnaire survey of symptoms and SPK scale classification, was administered preoperatively and 3 months postoperatively for evaluation. The median MRD-1 was 1 mm preoperatively and 2.5 mm postoperatively, representing a significant postoperative improvement. SPK area and density scores were found to increase when the MRD-1 increase was more than 2.5 mm with surgery. All 10 items on the questionnaire tended have increased scores after surgery, and significant differences were observed in 7 items (poor visibility, ocular fatigue, heavy eyelid, foreign body sensation, difficulty in focusing, headaches, and stiff shoulders). Blepharoptosis surgery was found to be a safe and effective way to maintain the increase in MRD-1 within 2.0 mm. Despite the benefits, surgeons must nonetheless be aware that blepharoptosis surgery is a delicate procedure in elderly people.
老年患者常出现睑下垂手术并发症,可导致浅层点状角膜炎(SPK)的出现或加重。然而,此前尚未报道过术后SPK状态的变化。我们通过对症状的主观评估和SPK量表分类测量,来研究老年患者睑下垂手术的安全性和有效性。
本前瞻性研究纳入了22例(44只眼)接受双侧睑下垂手术的患者。患者包括8名男性和14名女性,平均(±标准差)年龄为75.7±8.2岁(范围:61 - 89岁)。睑下垂手术包括经皮提上睑肌前移和眼睑成形术,包括软组织(皮肤、皮下组织和眼轮匝肌)切除术。术前和术后3个月进行边缘反射距离-1(MRD-1)测量、症状问卷调查和SPK量表分类,以进行评估。
术前MRD-1中位数为1mm,术后为2.5mm,术后有显著改善。当手术使MRD-1增加超过2.5mm时,发现SPK面积和密度评分增加。问卷中的所有10项内容术后得分均有增加趋势,7项内容(视力差、眼疲劳、上睑沉重、异物感、聚焦困难、头痛和肩部僵硬)有显著差异。
睑下垂手术被发现是一种将MRD-1增加维持在2.0mm以内的安全有效的方法。尽管有这些益处,但外科医生仍必须意识到睑下垂手术对老年人来说是一个精细的手术。